Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, CXP

COEUS Solutions Rebrands as BridgeView Life Sciences After Successful Spinoff


Company eyes global expansion and introduction of new solutions for life sciences industry's most pressing challenges

PAOLI, Pa., April 30, 2024 /PRNewswire/ -- COEUS Solutions, a leading provider of innovative technologies and services in the life sciences industry, today announces its rebranding to BridgeView Life Sciences ("BridgeView") following a recent spinoff from its former parent company. This marks a significant milestone for the company, signaling a new era of growth and scale to support life sciences companies in their commercial transformations.

Serving as a trusted solutions partner for life sciences organizations, BridgeView Life Sciences provides the strategic acumen, differentiated SaaS platforms and comprehensive services that customers need to plan, launch, operationalize and scale. The company's SaaS applications include DataBridgetm for commercial data warehouse, PatientBridgetm for specialty data aggregation, and CommandBridgetm for program management, each focused on driving insights to enable data-driven decision processes. BridgeView also has a broad portfolio of expert strategy consulting, implementation and managed services.

"With nearly a decade in the life sciences industry, COEUS Solutions has been serving clients with excellence, integrity and innovation," said Mike Zubey, CEO of BridgeView Life Sciences. "Our decision to rebrand as BridgeView Life Sciences shows the company's commitment to helping life sciences organizations optimize their operations. 'Bridge' refers to the gap between a client's current state and the path forward, and 'View' represents insights that our transformative technologies and services deliver."

BridgeView's rebranding includes a new company logo, website and communication materials that reflect the company's forward-thinking approach and dedication to the highest standards of service and integrity. BridgeView will ensure a seamless transition for clients, partners and other stakeholders.

"This spinoff frees the company to address new commercial challenges with expanded solution offerings and to deepen our partnerships across the life sciences industry. This includes providing the tools and talent clients need to deliver on commercial transformation initiatives ? from planning through value realization," added Zubey. "We are excited about the many opportunities to collaborate with current and future customers as BridgeView Life Sciences."

About BridgeView Life Sciences:
BridgeView Life Sciences is a leading provider of cutting-edge solutions in the life sciences industry, dedicated to empowering organizations with transformative services that drive efficiency, compliance and better patient outcomes. With a focus on collaboration, integrity and innovation, BridgeView is committed to bridging the gap between life sciences organizations and their goals. For more information, visit www.bridgeviewls.com.

Contact:
Emily Rodriguez
Public Relations Manager
BridgeView Life Sciences
Phone: (484) 433-6728
Email: [email protected]

SOURCE BridgeView Life Sciences


These press releases may also interest you

at 20:10
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...

at 19:20
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

at 18:50
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....

at 18:46
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

at 18:42
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...



News published on and distributed by: